Regencell Bioscience Holdings Limited
RGC Healthcare Drug Manufacturers Specialty & Generic
Dividend growth for three consecutive years.
Follow RGC
An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.
| Older periods | Jun '23 | Jun '24 | Jun '25 | Dec '25 | |
|---|---|---|---|---|---|
Gross Margin |
+7 more quarters Free account |
0.00% | — | — | — |
Net Profit Margin |
0.00% | — | — | — | |
| Other line items | |||||
EBT margin |
0.00% | — | — | — | |
EBITDA Margin |
0.00% | — | — | — | |
Operating Cash Flow Margin |
0.00% | 0.00% | 0.00% | 0.00% |